Proliferative phase sees enhanced cellular migration (TB-500) coupled with increased growth factor expression and vascular development (BPC-157)
For Canadian researchers, the operating reality in 2026 is a tightening Health Canada enforcement environment combined with a demanding documentation standard for any laboratory material
An approach based on targeted elimination of senescent cells allows the body to reactivate its natural function without the need for artificial replacements
Neumann SN, Li JJ, Yuan XD, Chen SH, Ma CR, Murray-Kolb LE, et al
The FDA has scheduled a Pharmacy Compounding Advisory Committee meeting for July 23, 2026 to review BPC-157 for the 503A Bulks List
Glutathione plays a crucial role in defending against these free radicals